🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of b...
Status
Recruiting
Location
Arizona Oncology - Tucson - Rudasill /ID# 267552
Start Date
2024-08-05
Trial ID
NCT06428019
Treatments Being Tested
An observational study to assess the effectiveness, health economic-relevan...
Status
Recruiting
Location
Universitaetsklinikum St. Poelten /ID# 221152
Start Date
2017-12-04
Trial ID
NCT03342144
This phase II trial is to evaluate the effects of acalabrutinib in combinat...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-05-31
Trial ID
NCT04941716
Many patients with CLL have a weakened immune system due to their disease. ...
Status
Recruiting
Location
Rigshospitalet
Start Date
2019-10-11
Trial ID
NCT03868722
Treatments Being Tested
Study to determine the preliminary safety, tolerability, and pharmacokineti...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2021-03-02
Trial ID
NCT04419389
The purpose of this study is to evaluate the efficacy and safety of acalabr...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-02-25
Trial ID
NCT03836261
Treatments Being Tested
This study will evaluate the efficacy and safety of finite-duration acalabr...
Status
Recruiting
Location
Research Site
Start Date
2026-06-04
Trial ID
NCT07024706
Treatments Being Tested
A Phase 1b, Multicenter, Open-label Study of Acalabrutinib in Combination w...
Status
Active Not Recruiting
Location
Research Site
Start Date
2016-04-20
Trial ID
NCT02717624
Treatments Being Tested
This is an open-label, multicenter, phase 2, non-randomized study aiming to...
Status
Recruiting
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2025-12-01
Trial ID
NCT06958705
To evaluate the safety and preliminary efficacy of acalabrutinib in combina...
Status
Completed
Location
Research Site
Start Date
2014-12-22
Trial ID
NCT02296918
Treatments Being Tested